NYSE:CVSHealthcare
A Look At CVS Health (CVS) Valuation After Tennessee Bill 2040 And Insurance Business Retrenchment
CVS Health (CVS) is in the spotlight after Tennessee Senate Bill 2040 advanced, threatening to force the closure of all company pharmacies in the state. CVS also plans to scale back Medicare Advantage and exit Obamacare exchanges.
See our latest analysis for CVS Health.
At a share price of US$79.90, CVS has seen a 7.22% 1 month share price return and a modest 2.94% 3 month share price return. Its 1 year total shareholder return of 27.81% points to stronger longer term momentum as investors...